Yaz, Yasmin Lawsuits Rise Amid Settlement ExpectationJul 26, 2012 | Parker Waichman LLP
Close to 80 new Yaz and Yasmin lawsuits have been filed since July 1 in the Yaz and Yasmin products liability litigation currently underway in U.S. District Court, Southern District of Illinois. The flurry of Yaz and Yasmin lawsuit filings come as word has emerged that cases are being settled, and speculation that the litigation could wrap up sometime within the next year.
According to a report from the Madison Record, 76 lawsuits have been filed in the litigation this month. Like other claims in the litigation, all of the complaints allege that Yaz and Yasmin caused young woman to experience dangerous blood clots, deep vein thrombosis, pulmonary embolism, heart attacks, strokes, gall bladder disease, and sudden death. All of the complaints accuse Bayer and other defendants of failing to adequately research their products and concealing the risks of the contraceptives.
Some 9,800 claims have been filed in the litigation so far, with around 1,500 reported settled. According to the Madison Record, the average settlement has come in around $214,000, with Bayer committing about $300 million so far. Most of the resolved cases involve injuries that resulted from blood clots.
Last month, Stephen Saltzburg, the Special Master assigned to the case told the Madison Record that he was cautiously optimistic that all of the complaints will be resolved within the next year. He also predicted that the number filings would increase, as attorneys learned of the momentum towards settlement.